Gryphon Financial Partners’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,490	Closed	-$104K	–	198
2022 Q3	$104K	Sell	10,490 -1,850	-15%	-$18.3K	0.03%	188
2022 Q2	$131K	Buy	12,340 +1,850	+18%	+$19.6K	0.03%	187
2022 Q1	$102K	Buy	+10,490	New	+$102K	0.02%	192